Elekta AB (EKTAY)

14.81 +0.21  +1.47% OTC Markets Jul 23, 20:00 USD
View Full Chart
Price Chart
View All EKTAY News


View All Events


Date Type Description
08/26/2021 Dividends 0.1269 Normal dividend, declared July 16, 2021 and paid September 16, 2021
08/25/2021 Earnings Results Q1 2022 Earnings Results
08/25/2021 Earnings Calls Q1 2022 Earnings Call
05/28/2021 Earnings Results Q4 2021 Earnings Results
05/28/2021 04:00 EST Earnings Calls Q4 2021 Earnings Call
04/19/2021 Dividends 0.1068 Normal dividend, declared April 19, 2021 and paid May 10, 2021
02/25/2021 Earnings Results Q3 2021 Earnings Results
02/25/2021 04:00 EST Earnings Calls Q3 2021 Earnings Call
11/26/2020 Earnings Results Q2 2021 Earnings Results
11/26/2020 04:00 EST Earnings Calls Q2 2021 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Elekta AB develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 4,500 platforms and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 38%; and Asia-Pacific contributing the remainder.
  • URL: https://www.elekta.com
  • Investor Relations URL: https://www.elekta.com/investors/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Equity Style: Mid Cap/Blend
  • Next Earnings Release: Aug. 25, 2021
  • Last Earnings Release: May. 28, 2021
  • Next Ex-Dividend Date: Aug. 26, 2021
  • Last Ex-Dividend Date: Apr. 19, 2021





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.